Treatment patterns in metastatic renal cell carcinoma in the US: a retrospective chart review

被引：0
|
作者：
Pal, Sumanta K. [1 ]
Jonasch, Eric [2 ]
Signorovitch, James E. [3 ]
Reichmann, William M. [3 ]
Liu, Zhimei [4 ]
Perez, Jose Ricardo [4 ]
Vogelzang, Nicholas J. [5 ]
机构：
[1] City Hope Comprehens Canc Ctr, Duarte, CA USA
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[3] Anal Grp Inc, Boston, MA USA
[4] Nova Pharmaceut Corp, E Hanover, NJ USA
[5] Comprehens Canc Ctr Nevada, US Oncol Res, Las Vegas, NV USA
来源：
BJU INTERNATIONAL | 2014年 / 114卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：13 / 13
页数：1
相关论文
共 50 条
  • [1] Treatment patterns in metastatic renal cell carcinoma in the US: a retrospective chart review in community oncology practices
    Vogelzang, N. J.
    Signorovitch, J. E.
    Lin, P. L.
    Liu, Z.
    Culver, K.
    Pal, S. K.
    Scott, J. A.
    Jonasch, E.
    BJU INTERNATIONAL, 2012, 110 : 13 - 14
  • [2] Treatment patterns in metastatic renal cell carcinoma: a retrospective review of medical records from US community oncology practices
    Jonasch, Eric
    Signorovitch, James E.
    Lin, Peggy L.
    Liu, Zhimei
    Culver, Ken
    Pal, Sumanta K.
    Scott, Jeffrey A.
    Vogelzang, Nicholas J.
    CURRENT MEDICAL RESEARCH AND OPINION, 2014, 30 (10) : 2041 - 2050
  • [3] Comparative effectiveness of everolimus and axitinib as second targeted therapies for metastatic renal cell carcinoma in the US: a retrospective chart review
    Vogelzang, Nicholas J.
    Pal, Sumanta K.
    Signorovitch, James E.
    Reichmann, William M.
    Li, Nanxin
    Yang, Chelsey
    Liu, Zhimei
    Perez, Jose Ricardo
    Jonasch, Eric
    CURRENT MEDICAL RESEARCH AND OPINION, 2016, 32 (04) : 741 - 747
  • [4] Safety and efficacy of nivolumab as a second line therapy in metastatic renal cell carcinoma: a retrospective chart review
    Gamulin, Marija
    Nham, Eric
    Rkman, Deni
    Golubi, Zrna Antunac
    Likic, Robert
    CROATIAN MEDICAL JOURNAL, 2020, 61 (04) : 326 - 332
  • [5] Changes in treatment patterns among patients receiving at least two targeted therapies for metastatic renal cell carcinoma (mRCC) in the US: A comparison of retrospective chart reviews conducted in 2012 and 2014
    Perez, Jose Ricardo
    Pal, Sumanta Kumar
    Signorovitch, James E.
    Reichmann, William M.
    Li, Nanxin
    Liu, Zhimei
    Jonasch, Eric
    Vogelzang, Nicholas J.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [6] Clinical outcomes and dosing patterns of 2nd targeted therapy in metastatic renal carcinoma: a retrospective chart review in the EU
    Heng, D.
    Park, J.
    Signorovitch, J. E.
    Yang, H.
    Song, J.
    Weiss, J.
    Dezzani, L.
    Powles, T. B.
    ANNALS OF ONCOLOGY, 2016, 27
  • [7] Treatment options for metastatic renal cell carcinoma: a review
    Athar, Uzma
    Gentile, Teresa C.
    CANADIAN JOURNAL OF UROLOGY, 2008, 15 (02) : 3954 - 3966
  • [8] Review of guidelines on the treatment of metastatic renal cell carcinoma
    Soulieres, D.
    CURRENT ONCOLOGY, 2009, 16 : S69 - S72
  • [9] Outcomes of second targeted therapy in metastatic renal carcinoma: A retrospective chart review in the EU.
    Heng, Daniel Yick Chin
    Park, Jinhee
    Signorovitch, James E.
    Yang, Hongbo
    Song, Jinlin
    Patel, Dony
    Lin, Chinjune
    Powles, Thomas
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [10] Angiogenesis inhibitor therapies for metastatic renal cell carcinoma: effectiveness, safety and treatment patterns in clinical practice-based on medical chart review
    Choueiri, Toni K.
    Duh, Mei Sheng
    Clement, Jessica
    Brick, Ashley J.
    Rogers, Miranda J.
    Kwabi, Christabel
    Shah, Karishma
    Percy, Andrew G.
    Antras, Lucia
    Jayawant, Sujata S.
    Chen, Kristina
    Wang, Si-Tien
    Luka, Andi
    Neary, Maureen P.
    McDermott, David
    Oh, William K.
    BJU INTERNATIONAL, 2010, 105 (09) : 1247 - 1254
12345